Stock PSTV PLUS THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Plus Therapeutics, Inc.

Equities

PSTV

US72941H5090

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
1.69 USD +1.50% Intraday chart for Plus Therapeutics, Inc. +3.68% -3.43%
Apr. 22 Plus Therapeutics Gets $3 Million Funding Recommendation From Department of Defense MT
Apr. 22 Plus Therapeutics, Inc. Receives $3 Million Award Recommendation from the United States Department of Defense CI

Evolution of the average Target Price on Plus Therapeutics, Inc.

Price target over the last 5 years

History of analyst recommendation changes

c3f55d0206129955e94c30.1RyKvdH1rm8zlHoYjm8p0yl5XRVep3TKOV7zTO7noL0.pmnZy6WymSBd4SJe6AIdmB44BXg9ihb4AG-HL4-m5syzaf_8s4XCXQfZFQ~3136c36b8e441a7151e7434e92f12c6b

Analyst Recommendations on Plus Therapeutics, Inc.

Wall Street Set to Open Flat Friday as Investors Remain Wary of Potential Interest Rate Hike MT
HC Wainwright Adjusts Price Target on Plus Therapeutics to $8 From $3.50, Maintains Buy Rating MT
Maxim Adjusts Price Target on Plus Therapeutics to $12 From $30, Maintains Buy Rating MT
JonesTrading Starts Plus Therapeutics at Buy With $5 Price Target MT
HC Wainwright Adjusts Plus Therapeutics' Price Target to $3.50 from $7, Keeps Buy Rating MT
PLUS THERAPEUTICS : HC Wainwright Starts Plus Therapeutics at Buy With $7 Price Target MT
PLUS THERAPEUTICS : Ladenburg Thalmann Starts Plus Therapeutics at Buy With $8 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
1.69 USD
Average target price
11.33 USD
Spread / Average Target
+570.61%
High Price Target
22 USD
Spread / Highest target
+1,201.78%
Low Price Target
4 USD
Spread / Lowest Target
+136.69%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Plus Therapeutics, Inc.

HC Wainwright
Maxim
JonesTrading Institutional Services
Ladenburg Thalmann

Ratings for Plus Therapeutics, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. PSTV Stock
  4. Consensus Plus Therapeutics, Inc.